Ultra-Early Vasopressin Shows Promise in Septic Shock, But Randomized Trial Evidence Still Missing
A new target trial emulation links ultra-early vasopressin initiation to lower mortality in septic shock, but randomized trial evidence remains ...
A new target trial emulation links ultra-early vasopressin initiation to lower mortality in septic shock, but randomized trial evidence remains ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.